Bone Biologics announced the engagement of Scott D. Boden, MD as Chief Medical Advisor. Dr. Boden is a tenured Professor of Orthopaedic Surgery at the Emory University School of Medicine, serves as the Director of the Emory Orthopeadics & Spine Center, Vice Chair of Orthopeadics, CMO/CQO of The Emory University Orthopeadics & Spine Hospital and Emory Healthcare Physician Director of Strategy and Development for Orthopeadics & Spine Programs. He is also the Clinical Director of the Whitesides Orthopedic Research Laboratory.
Dr. Boden’s laboratory at Emory University conducts research and has clinical expertise focused on small molecules that are osteoinductive and target different aspects of the musculoskeletal tissue formation pathway and large molecules that include protein, amino acids and designer chemicals. His achievements include: the discovery of four families of osteoinductive small molecules, safety /toxicity and efficacy profiling, completion of cell culture step, completion of rodent studies for one family of molecules and carrier supplier identified and contracted.
Dr. Boden has received numerous awards for his work and is the author of more than 175 peer-reviewed articles on spine and basic science topics including a paper published for the Journal of Bone and Joint Surgery, as well as 30 chapters and seven textbooks. He is co-editor of Seminars in Spine Surgery, a deputy editor of SPINE and a reviewer for the Journal of Bone and Joint Surgery, the Journal of Bone and Mineral Research as well as the European Spine Journal.
Most recently, Dr. Boden served as President of the American Orthopedic Association. He received his B.A. and M.D. from the University of Pennsylvania and completed an Orthopedic Residency at The George Washington University Medical Center, followed by a Spine Fellowship at Case Western Reserve University Hospitals.